Stemina Biomarker Discovery Raises $1M in Angel Funds | GenomeWeb

NEW YORK (GenomeWeb News) – Stemina Biomarker Discovery said this week that it has raised $1 million in angel investments to further develop its product for assessing drug toxicity in the developing human embryo.

Angel groups DaneVest Tech Fund Advisors, Phenomenelle Angels, and Wisconsin Investment Partners all contributed to the financing.

Stemina said that it plans to raise a total of $3 million in the financing round. In addition, the company said that it was recently awarded a $150,000 grant from the National Science Foundation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.